Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating substance-use disorders among physicians

R E Herrington, D G Benzer, G R Jacobson

    JAMA
    |April 23, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stress impairment in physicians.

    WMJ : official publication of the State Medical Society of Wisconsin·2001
    Same author

    Subunit and amino acid interactions in the Escherichia coli mannitol permease: a functional complementation study of coexpressed mutant permease proteins.

    Journal of bacteriology·1997
    Same author

    A conserved glutamate residue, Glu-257, is important for substrate binding and transport by the Escherichia coli mannitol permease.

    Journal of bacteriology·1997
    Same author

    Isolation and characterization of a mutation that alters the substrate specificity of the Escherichia coli glucose permease.

    Journal of bacteriology·1996
    Same author

    The disruptive-abusive physician: a new look at an old problem.

    Wisconsin medical journal·1995
    Same author

    Overexpression, phosphorylation, and growth effects of ORF162, a Klebsiella pneumoniae protein that is encoded by a gene linked to rpoN, the gene encoding sigma 54.

    FEMS microbiology letters·1994
    Same journal

    Online Prescribing of GLP-1 Receptor Agonists.

    JAMA·2026
    Same journal

    Using AI Disagreement to Expose Gaps in Coverage Rules.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy-Reply.

    JAMA·2026
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    See all related articles

    Physician addiction rehabilitation programs show positive outcomes. Most physicians in treatment return to practice, with many achieving long-term recovery and avoiding relapse.

    Area of Science:

    • Addiction Medicine
    • Physician Health Programs

    Background:

    • Physician impairment due to alcohol and other drug dependence is a significant concern.
    • Rehabilitation programs are crucial for supporting affected medical professionals.

    Purpose of the Study:

    • To evaluate the efficacy of a two-year rehabilitation program for alcohol- and other-drug-dependent physicians.
    • To assess treatment completion rates, return to practice, and relapse rates.

    Main Methods:

    • A cohort of 40 physicians participated in a structured, two-year treatment and monitoring program.
    • Data collected on treatment duration, completion, return to practice, and relapse status.

    Main Results:

    • Out of 40 participants, 15 completed 24 months, 8 completed 12-23 months, 10 completed 1-11 months, and 7 discontinued.

    Related Experiment Videos

  • Of 33 treated physicians, 31 returned to full practice, and 22 experienced no relapse.

    • Conclusions:

    • The prognosis for impaired physicians in appropriate rehabilitation programs is favorable.
    • Effective treatment, monitoring, and follow-up are key to successful recovery and return to practice.